Previous Close | 31.64 |
1-Year Change | -31.85% |
6-Months Change | -19.7% |
3-Months Change | -18.83% |
Moving Avg (50d) | 36.079 |
Moving Avg (200d) | 40.476 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 0.605B |
Beta (3-Years) | 0.66 |
Revenue Growth (ttm) | -10.6% |
Net Profit Margin (ttm) | 6.45% |
Return On Assets (ttm) | 9.95% |
EPS (ttm) | 3.09 |
PE Ratio (ttm) | 10.24 |
Dividend Yield | % |
Asset Description: | USANA Health Sciences, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-03 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
32.273 | 33.222 | 33.855 | 34.804 | 36.386 | 37.968 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.